Replies to post #4613 on OncoSec Medical Inc (ONCSQ)

[murocman]

The Bull case is to raise money before strong results that will create demand for shares to soak up the dilution and still raise the floor price. The Bear case is do it now in case results are bad and shares become much cheaper.
I'm long and therefore a bull. This is not atypical for a biotech company as they need to prepare for success and be able to fund future trials and continue to advance their pipeline.

My two cents,

Murocman

[erostratus]

I had assumed that at their current burn rate they might have not needed to do it for at least till the end of the year but on the other hand, I'm glad they intend to get it over with.
As someone else said; time to load up the cheapies when it's finalized.
Also, I'm sure that incoming financing has prevented a good number of eager DD investors from entering the stock as of yet, with the idea of jumping in once it's finalized. With increased attention to the fact that ONCS results are unmatched by other skin cancer trials, there has been considerable buzz surrounding ONCS as a favorite in melanoma and I would not be surprised by a full rebound within days.

$ONCS